| SC 13G/A | 2022-09-12 | FMR LLC | ChemoCentryx, Inc. | 7,734 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | RA CAPITAL MANAGEMENT, L.P. | ChemoCentryx, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Schall Thomas J. | ChemoCentryx, Inc. | 4,525,787 | 6.5% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | ChemoCentryx, Inc. | 10,504,719 | 15.0% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | ChemoCentryx, Inc. | 5,098,980 | 7.3% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | ChemoCentryx, Inc. | 4,326,487 | 6.2% | EDGAR |
| SC 13D/A | 2021-10-14 | Vifor (International) Ltd | ChemoCentryx, Inc. | 1,860,752 | 2.7% | EDGAR |
| SC 13G/A | 2021-06-09 | WELLINGTON MANAGEMENT GROUP LLP | ChemoCentryx, Inc. | 482,747 | 0.7% | EDGAR |
| SC 13G/A | 2021-02-16 | Cormorant Asset Management, LP | ChemoCentryx, Inc. | 1,154,566 | - | EDGAR |
| SC 13G/A | 2021-02-16 | RA CAPITAL MANAGEMENT, L.P. | ChemoCentryx, Inc. | 4,776,548 | 6.9% | EDGAR |
| SC 13G/A | 2021-02-16 | Schall Thomas J. | ChemoCentryx, Inc. | 4,337,412 | 6.3% | EDGAR |
| SC 13G | 2021-02-10 | VANGUARD GROUP INC | ChemoCentryx, Inc. | 4,747,470 | 6.9% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | ChemoCentryx, Inc. | 10,381,262 | 15.0% | EDGAR |
| SC 13G/A | 2021-02-03 | WELLINGTON MANAGEMENT GROUP LLP | ChemoCentryx, Inc. | 6,148,679 | 8.9% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | ChemoCentryx, Inc. | 4,804,697 | 6.9% | EDGAR |
| SC 13G | 2020-11-10 | WELLINGTON MANAGEMENT GROUP LLP | ChemoCentryx, Inc. | 7,014,146 | 10.2% | EDGAR |
| SC 13D/A | 2020-07-31 | Vifor (International) Ltd | ChemoCentryx, Inc. | 5,950,412 | 8.8% | EDGAR |
| SC 13D/A | 2020-07-16 | Vifor (International) Ltd | ChemoCentryx, Inc. | 6,643,790 | 9.8% | EDGAR |
| SC 13G/A | 2020-02-14 | BIOTECHNOLOGY VALUE FUND L P | ChemoCentryx, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2020-02-14 | RA CAPITAL MANAGEMENT, L.P. | ChemoCentryx, Inc. | 3,199,389 | 5.5% | EDGAR |